KLK9 and ovarian serous adenocarcinoma: In summary, whereas KLK9 and KLK10 mRNA expression does not display any prognostic power in advanced high-grade serous ovarian cancer (FIGO stage III/IV), high KLK15 and, especially, KLK11 mRNA levels are associated with better outcome.